Section Arrow
Quote
CRL.NYSE
- Charles River Laboratories International
Quotes are at least 15-min delayed:2026/09/01 22:26 EDT
Regular Hours
Last
 282.34
-5.9 (-2.05%)
Day High 
290.5299 
Prev. Close
288.24 
1-M High
303.305 
Volume 
705.71K 
Bid
276.53
Ask
298
Day Low
280.91 
Open
289.26 
1-M Low
228.01 
Market Cap 
13.76B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 292.33 
20-SMA 282.12 
50-SMA 247.17 
52-W High 303.305 
52-W Low 144.26 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-4.81/12.33
Enterprise Value
16.33B
Balance Sheet
Book Value Per Share
59.48
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
4.02B
Operating Revenue Per Share
88.31
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
BIAFbioAffinity Technologies Inc6.59+2.03+44.52%-- 
PSNLPersonalis17.06+0.28+1.67%-- 
DHRDanaher Corp206.93-6.63-3.10%38.07PE
RVTYRevvity126.59-2.08-1.62%61.86PE
OPKOPKO Health1.52+0.05+3.40%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.